Q&A with BHI Expert Data Analysts In our latest Q&A, Carolyn Jevit, senior product director, discusses how BHI’s National Benchmarking Module (NBM) uses data to provide health plans and their employer customers with a deeper understanding of cost and utilization improvement opportunities at national, regional, plan, and account levels.
Q&A: The Importance of REL Data in Achieving Health Equity
Q&A with BHI Expert Data Analysts Almost all commercial health plans are seeking to address health disparities, but few have the reliable and widespread race, ethnicity, and language (REL) data needed. Learn how, in the absence of self-reported data, Plans can continue to make progress.
Study: Telehealth Consults Increased Over 50-Fold During First Phase of Pandemic
An article in Care Analytic News discusses the findings from a recent study co-authored by researchers at the Johns Hopkins Bloomberg School of Public Health and Blue Health Intelligence®. The study found that telehealth consults among privately insured working-age patients accounted for almost 24 percent of outpatient consults with health care providers during the early phase of the pandemic, March … Read More
Using BHI data to assess the impact of COVID-19 on telehealth utilization
The explosive growth of telehealth has been discussed extensively in the past year. To provide even greater insights into the nature of this COVID-19 driven-trend, BHI studied our conformed national medical claims data set, comprised of more than 22 billion claims that represent 217 million unique lives, to unearth different telehealth insights.
BHI 2020 Year-end Data Digest
Throughout 2020, Blue Health Intelligence® (BHI®) used its access to more than 20 billion claims from over 200 million unique members to examine healthcare trends affecting the health of millions of Americans. This digest contains five studies on the following topics: COVID-19, men’s health, UV safety, HPV vaccinations, and childhood obesity.
Using BHI Data to Uncover Secondary Impacts of COVID-19
This brief examines COVID-19’s impact on preventive services and telehealth using national claims data from 2019 and 2020. The descriptive studies of preventive service episodes included doctor visits and related preventive screenings such as mammograms, pap smears, and colonoscopies. The study also looks at differences in the use of preventive services and telehealth between urban and rural areas.
BHI Data Report: Using Data in the Fight Against Breast Cancer
Blue Health Intelligence® (BHI®) examined breast cancer rates in women between 40 and 64 years of age using national commercial claims data from 2016 through 2019. The study looked at costs and trends over the four years with a brief look into how the pandemic affected breast cancer screening and diagnostic mammograms utilization in 2020.
Cost of Care Snapshot: 3-Year Trends
In this report, Blue Health Intelligence® (BHI®) presents a summary of recent healthcare trends using claims data from the most trusted commercial health plans. In looking across all this information, three trends continue to rise to the surface: Cost increases are outpacing healthcare utilization. Care settings continue to have a huge impact on costs. The prescription drug cost gap is still … Read More
The Impact of Caregiving on Mental and Physical Health
In this Health of America report, the Blue Cross Blue Shield Association, in collaboration with Blue Health Intelligence, examines the role that caregivers play an important role in the U.S. healthcare system. The commitment of time, labor and emotional support this role requires can have a substantial impact on caregivers’ physical, behavioral and emotional well-being.
Rise in Chronic Conditions is Putting More Americans at Risk for Colorectal Cancer
In this Health of America report, the Blue Cross Blue Shield(BCBS) Association, in collaboration with Blue Health Intelligence, examines the rate of colorectal cancer diagnoses and preventive screenings, as well as the reasons why two of the most at-risk populations of commercially insured Americans say they avoid or delay screening.